Boston Scientific's Valuation After Penumbra Deal and Recent Share Moves: A Closer Look

Boston Scientific's (BSX) stock has seen mixed returns, with a recent gain of 2.55% over the past week but declines of 6.67% over the past month and 90 days. The stock has a three-year total shareholder return of 102.40% and a five-year total shareholder return of 155.49%. The current share price of $93.61 is slightly below the narrative fair value of $98.90, due to concerns about earnings dilution and increased debt load from the Penumbra acquisition.